Clinuvel Pharmaceuticals Ltd. (CUVL)
6.01
-0.51
(-7.82%)
USD |
NASDAQ |
Sep 08, 16:00
6.07
+0.06
(+1.00%)
Pre-Market: 20:00
Clinuvel Pharmaceuticals Market Cap : 303.07M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 303.07M |
| September 04, 2026 | 328.79M |
| September 03, 2026 | 316.69M |
| September 02, 2026 | 312.65M |
| September 01, 2026 | 314.67M |
| August 31, 2026 | 300.05M |
| August 28, 2026 | 310.64M |
| August 27, 2026 | 341.40M |
| August 26, 2026 | 385.48M |
| August 25, 2026 | 383.25M |
| August 24, 2026 | 374.18M |
| August 21, 2026 | 393.34M |
| August 20, 2026 | 393.34M |
| August 19, 2026 | 360.56M |
| August 18, 2026 | 347.95M |
| August 17, 2026 | 346.69M |
| August 14, 2026 | 347.95M |
| August 13, 2026 | 339.13M |
| August 12, 2026 | 336.86M |
| August 11, 2026 | 345.94M |
| August 10, 2026 | 339.88M |
| August 07, 2026 | 336.61M |
| August 06, 2026 | 339.08M |
| August 05, 2026 | 327.99M |
| August 04, 2026 | 344.93M |
| Date | Value |
|---|---|
| August 03, 2026 | 349.97M |
| July 31, 2026 | 327.28M |
| July 30, 2026 | 349.47M |
| July 29, 2026 | 344.17M |
| July 28, 2026 | 353.50M |
| July 27, 2026 | 353.50M |
| July 24, 2026 | 350.47M |
| July 23, 2026 | 350.47M |
| July 22, 2026 | 353.00M |
| July 21, 2026 | 354.00M |
| July 20, 2026 | 373.17M |
| July 17, 2026 | 370.65M |
| July 16, 2026 | 359.55M |
| July 15, 2026 | 363.50M |
| July 14, 2026 | 356.53M |
| July 13, 2026 | 367.62M |
| July 10, 2026 | 365.10M |
| July 09, 2026 | 361.06M |
| July 08, 2026 | 349.47M |
| July 07, 2026 | 364.59M |
| July 06, 2026 | 368.12M |
| July 02, 2026 | 370.65M |
| July 01, 2026 | 370.65M |
| June 30, 2026 | 368.12M |
| June 29, 2026 | 361.32M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alterity Therapeutics Ltd. | 81.75M |
| Kazia Therapeutics Ltd. | 136.15M |
| Algorae Pharmaceuticals Ltd. | 19.34M |
| Immuron Ltd. | 14.85M |
| Amplia Therapeutics Ltd. | 51.31M |
Market Cap Related Metrics
| PE Ratio | 13.07 |
| PS Ratio | 4.739 |
| PEG Ratio | 42.80 |
| Price to Free Cash Flow | 12.29 |
| Price | 6.01 |
| Earnings Yield | 7.65% |
| PEGY Ratio | 14.50 |
| Operating PE Ratio | 10.90 |
| Normalized PE Ratio | 13.07 |